Shares of C4X Discovery Holdings plc (LON:C4XD – Get Free Report) traded up 27.3% during trading on Thursday . The stock traded as high as GBX 12 ($0.15) and last traded at GBX 12 ($0.15). 3,770,459 shares traded hands during trading, an increase of 219% from the average session volume of 1,183,176 shares. The stock had previously closed at GBX 9.43 ($0.12).
C4X Discovery Price Performance
The company has a quick ratio of 9.82, a current ratio of 15.31 and a debt-to-equity ratio of 1.05. The firm has a market capitalization of £30.27 million, a price-to-earnings ratio of 300.00 and a beta of 0.23. The company’s 50 day moving average is GBX 12 and its 200 day moving average is GBX 11.65.
About C4X Discovery
C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.
See Also
- Five stocks we like better than C4X Discovery
- What to Know About Investing in Penny Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What Is WallStreetBets and What Stocks Are They Targeting?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is Forex and How Does it Work?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for C4X Discovery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C4X Discovery and related companies with MarketBeat.com's FREE daily email newsletter.
